Key Facts:
- 100% specialized in the pharmaceutical and biotech industry
- Founded in 1997
- Proven consulting capabilities with in-depth operational knowledge of the industry
- Hundreds of consultants in multiple offices in North America and Europe
- Stellar client satisfaction track record (average of 9.5 out of 10 in customer surveys)
- More than 90% of business from satisfied repeat clients
EXECUTIVE BIOS
Founder, Chairman, and Chief Executive Officer
John J. Campbell is the founder, chairman, and chief executive officer of Campbell Alliance, the leading specialized management consulting firm serving the pharmaceutical and biotech industries. He also serves as the chairman of the Pharmaceutical Institute, a provider of educational and information resources to companies in the pharmaceutical and biotech sector. Before founding Campbell Alliance in 1997, John Campbell was vice president of a subsidiary of the “top five” pharmaceutical company GlaxoSmithKline (then Glaxo Wellcome).
Today, Campbell Alliance has a team of more than 170 highly experienced professionals and a client base that includes most of the world’s leading pharmaceutical and biotech companies. Its eight offices are located in major life sciences hubs throughout the
In 2006, John Campbell was named an Ernst &Young Entrepreneur of the Year, and one of the “100 Most Inspirational People in the Pharmaceutical Industry” by PharmaVoice magazine. He is also the co-author of a best-selling book on the pharmaceutical industry, Understanding Pharma.
Mr. Campbell earned an MBA from William & Mary in Williamsburg, Virginia, and received his BBA, summa cum laude, from Pace University in New York.
President
Before joining Campbell Alliance, Ann Campbell was a Vice President with Bricker & Associates, an operational improvement consulting firm and wholly owned subsidiary of Keane, Inc. She also held management, technical, marketing, and sales positions for a major hardware and software vendor.
Ms. Campbell graduated with distinction from Northwestern University's Kellogg Graduate School of Management, earning a Master of Management degree with concentrations in Marketing and Organizational Behavior. She has a Bachelor's degree in Mathematical Sciences with a concentration in Computer Science from the University of North Carolina at Chapel Hill.
Video Feature
Thought Leadership
The oncology market has changed dramatically over the last 10 years. These changes have been brought about by 10 transformative trends, the effects of which will only intensify in the coming decade. Campbell Alliance’s Landmark Study, the ONC Study, analyzes these trends and explains their implications for leaders in the pharmaceutical and biotech industry...
Feature Articles


